22 February 2021 Introducing the Upcoming AMRA® MAsS Scan Report - to Help Clinicians Assess Sarcopenia More Accurately After a Rapid MRI
[Click on the image above to watch the video] Sweden, Linköping: Tuesday, February 22, 2021…
Now you can access multiple body composition biomarkers and disease insights through a rapid MRI. Get to know AMRA's solutions for your clinical and research needs.
As healthcare advances in better understanding individual variability in genetics, lifestyle, and biology, body composition assessment often remains imprecise and impersonal.
AMRA is the game-changer. Rapid whole-body MRI and automated, cloud-based image analysis now allow you to monitor small, clinically relevant changes in fat and muscle volumes. Simple, safe, and cost-effective – you send us images; we give precise, individualized body composition measurements and contextual disease insights.
MEDICAL RESEARCH
Data-driven trial optimization by advancing clinical research and its therapeutic application.
MEDICAL RESEARCH
Providing medical insights to unlock breakthroughs within the field of precision medicine.
MEDICAL DEVICE
Supporting the prediction and prevention of disease and the availability of more informed personalized treatments.
MEDICAL DEVICE
Clinical decision support on interventions including transplantation, exercise, nutrition and pharmacological therapies.
LINKÖPING, Sweden; February 16, 2021 – AMRA Medical will be introducing MAsS (Muscle Assessment Score) and AMRA®️ MAsS Scan at American Society of Transplantation CEoT Virtual Meeting 2021 on February 25-27th. Click on the video above or read more here.
[Click on the image above to watch the video] Sweden, Linköping: Tuesday, February 22, 2021…
[Click on the image to view the review summary video] Experts from Axcella Health, AMRA…